• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌门静脉侵犯的相关因素:232例未经术前治疗的手术切除病例的单因素和多因素分析

Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments.

作者信息

Adachi E, Maeda T, Kajiyama K, Kinukawa N, Matsumata T, Sugimachi K, Tsuneyoshi M

机构信息

Second Department of Pathology, Kyushu University, Fukuoka, Japan.

出版信息

Cancer. 1996 May 15;77(10):2022-31. doi: 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO;2-S.

DOI:10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO;2-S
PMID:8640665
Abstract

BACKGROUND

The postoperative intrahepatic recurrence of hepatocellular carcinoma (HCC) is high. It is difficult to distinguish whether the recurrence is metastatic or new primary lesion. To determine the malignant potential of HCC itself, we analyzed the risk factors associated with portal venous invasion since this is direct evidence of tumor invasiveness.

METHODS

Two hundred and thirty-two patients who underwent curative hepatectomy for HCC without preoperative treatments were included in this study, because preoperative treatment caused the tumor to undergo a variety of histologic change. We analyzed the risk factors linked to portal venous invasion by both univariate and multivariate analyses.

RESULTS

In an univariate analysis, tumors larger than 3 cm, high histologic grade (III or IV), the presence of fibrous capsule, necrosis, mitotic rate of more than 4/10 high power fields, peliotic change, presence of tumor giant cells, high platelet count, low level of indocyanine green retention rate at 15 minutes, and the absence of cirrhosis were significantly correlated with portal venous invasion. In multiple stepwise logistic regression analysis, tumors larger than 3 cm, high histologic grades, and the presence of fibrous capsule were strong predictors of portal venous invasion by HCC.

CONCLUSIONS

Because the blood vessels of the fibrous capsule were frequently invaded by cancer cells, it may have been possible to prevent postoperative metastatic recurrence if HCC were resected before becoming large enough to have a fibrous capsule.

摘要

背景

肝细胞癌(HCC)术后肝内复发率很高。很难区分复发是转移性的还是新的原发性病变。为了确定HCC本身的恶性潜能,我们分析了与门静脉侵犯相关的危险因素,因为这是肿瘤侵袭性的直接证据。

方法

本研究纳入了232例未接受术前治疗而行根治性肝切除术治疗HCC的患者,因为术前治疗会使肿瘤发生多种组织学变化。我们通过单因素和多因素分析来分析与门静脉侵犯相关的危险因素。

结果

在单因素分析中,肿瘤大于3 cm、高组织学分级(III或IV级)、存在纤维包膜、坏死、有丝分裂率超过4/10个高倍视野、紫癜样改变、存在肿瘤巨细胞、血小板计数高、15分钟时吲哚菁绿潴留率低以及无肝硬化与门静脉侵犯显著相关。在多步逻辑回归分析中,肿瘤大于3 cm、高组织学分级以及存在纤维包膜是HCC门静脉侵犯的强预测因素。

结论

由于纤维包膜的血管常被癌细胞侵犯,如果在HCC形成足够大的纤维包膜之前进行切除,可能预防术后转移性复发。

相似文献

1
Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments.肝细胞癌门静脉侵犯的相关因素:232例未经术前治疗的手术切除病例的单因素和多因素分析
Cancer. 1996 May 15;77(10):2022-31. doi: 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO;2-S.
2
Predictors of hepatic venous trunk invasion and prognostic factors in patients with hepatocellular carcinomas that had come into contact with the trunk of major hepatic veins.与肝静脉主干接触的肝细胞癌患者肝静脉主干侵犯的预测因素及预后因素
J Hepatobiliary Pancreat Surg. 2007;14(3):289-96. doi: 10.1007/s00534-006-1142-0. Epub 2007 May 29.
3
Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma.门静脉侵犯:是肝细胞癌术后即刻复发的唯一最独立的危险因素。
J Gastroenterol Hepatol. 2011 Nov;26(11):1646-51. doi: 10.1111/j.1440-1746.2011.06780.x.
4
Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.肝细胞癌患者的微血管侵犯及其可预测的临床病理因素。
Ann Surg Oncol. 2008 May;15(5):1375-82. doi: 10.1245/s10434-008-9846-9. Epub 2008 Mar 7.
5
Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.影响肝细胞癌侵犯门静脉患者预后的因素——对952例连续性肝细胞癌患者的回顾性分析
Hepatogastroenterology. 2003 Nov-Dec;50(54):2035-9.
6
Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma--results of 152 resected cases.肝细胞癌根治性肝切除术后复发模式相关的临床病理危险因素——152例切除病例的结果
Hepatogastroenterology. 2007 Oct-Nov;54(79):2084-7.
7
The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.术前血清乙肝e抗原阳性并不影响乙肝病毒相关肝细胞癌根治性切除术后的总生存期。
J Gastroenterol Hepatol. 2009 Mar;24(3):391-8. doi: 10.1111/j.1440-1746.2008.05637.x. Epub 2009 Nov 20.
8
Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy.肝切除术后源于残留癌细胞的肝细胞癌复发的危险因素。
Hepatogastroenterology. 1999 Jul-Aug;46(28):2469-75.
9
[Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].[血管内皮生长因子(VEGF)家族成员表达与乙肝相关肝细胞癌肝切除术后预后]
Korean J Hepatol. 2008 Jun;14(2):185-96. doi: 10.3350/kjhep.2008.14.2.185.
10
Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.丙型肝炎相关肝细胞癌肝移植术后生存的预测因素
Liver Transpl. 2004 Dec;10(12):1478-86. doi: 10.1002/lt.20303.

引用本文的文献

1
Associations Between Single Nucleotide Polymorphisms of Hypoxia-Related Genes and Capsule Formation in Hepatocellular Carcinoma.缺氧相关基因单核苷酸多态性与肝细胞癌包膜形成的相关性
J Hepatocell Carcinoma. 2023 Oct 10;10:1785-1797. doi: 10.2147/JHC.S417830. eCollection 2023.
2
Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges.复发性肝细胞癌的外科治疗:现状与挑战
World J Gastrointest Surg. 2023 Apr 27;15(4):544-552. doi: 10.4240/wjgs.v15.i4.544.
3
Identification of the origin of tumor in vein: comparison between CEUS LI-RADS v2017 and v2016 for patients at high risk.
静脉肿瘤起源的鉴别:LI-RADS v2017 与 v2016 对比在高危患者中的应用。
BMC Med Imaging. 2022 Oct 29;22(1):186. doi: 10.1186/s12880-022-00912-4.
4
Preoperative Prediction of Microvascular Invasion in Patients With Hepatocellular Carcinoma Based on Radiomics Nomogram Using Contrast-Enhanced Ultrasound.基于超声造影放射组学列线图对肝细胞癌患者微血管侵犯的术前预测
Front Oncol. 2021 Sep 7;11:709339. doi: 10.3389/fonc.2021.709339. eCollection 2021.
5
What is the optimal surgical treatment for hepatocellular carcinoma beyond the debate between anatomical versus non-anatomical resection?除了解剖性与非解剖性肝切除之争外,肝细胞癌的最佳手术治疗方法是什么?
Surg Today. 2022 Jun;52(6):871-880. doi: 10.1007/s00595-021-02352-z. Epub 2021 Aug 14.
6
Tumor size may influence the prognosis of solitary hepatocellular carcinoma patients with cirrhosis and without macrovascular invasion after hepatectomy.肿瘤大小可能会影响无大血管侵犯肝硬化单发肝细胞癌患者术后的预后。
Sci Rep. 2021 Aug 11;11(1):16343. doi: 10.1038/s41598-021-95835-5.
7
Radiomics analysis of [F]FDG PET/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinoma.基于[F]FDG PET/CT 的影像组学分析对极早期和早期肝细胞癌微血管侵犯及预后预测的价值
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2599-2614. doi: 10.1007/s00259-020-05119-9. Epub 2021 Jan 8.
8
CT Image-Based Texture Analysis to Predict Microvascular Invasion in Primary Hepatocellular Carcinoma.基于 CT 图像的纹理分析预测原发性肝细胞癌中的微血管侵犯。
J Digit Imaging. 2020 Dec;33(6):1365-1375. doi: 10.1007/s10278-020-00386-2. Epub 2020 Sep 23.
9
Next-generation des-r-carboxy prothrombin for immunohistochemical assessment of vascular invasion by hepatocellular carcinoma.用于肝细胞癌血管侵犯免疫组织化学评估的新一代去γ-羧基凝血酶原
BMC Surg. 2020 Sep 14;20(1):201. doi: 10.1186/s12893-020-00862-0.
10
Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma.肝动脉灌注化疗与经导管动脉栓塞术治疗巨大不可切除肝细胞癌患者的比较
Medicine (Baltimore). 2020 Aug 7;99(32):e21489. doi: 10.1097/MD.0000000000021489.